Details for New Drug Application (NDA): 071922
✉ Email this page to a colleague
The generic ingredient in METHYLDOPA AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; methyldopa. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; methyldopa profile page.
Summary for 071922
Tradename: | METHYLDOPA AND HYDROCHLOROTHIAZIDE |
Applicant: | Watson Labs |
Ingredient: | hydrochlorothiazide; methyldopa |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 30MG;500MG | ||||
Approval Date: | Aug 29, 1988 | TE: | RLD: | No |
Complete Access Available with Subscription